Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Dose Discovery Analysis of Zoledronic Acid With Concurrent Chemotherapy in the Treatment of Newly Diagnosed Metastatic Osteosarcoma

NCT00742924 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00742924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00742924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Dose Discovery Analysis of Zoledronic Acid With Concurrent Chemotherapy in the Treatment of Newly Diagnosed Metastatic Osteosarcoma
Lead sponsor
Children's Oncology Group
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2008
Completion date
Not reported
Enrollment
24 (actual)
Sites
88

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma